Pediatric COVID-19 ─ What kind of disease is it?

Authors

  • Luis Salazar Department of Pediatrics, Centro Materno-Infantil do Norte, Centro Hospitalar e Universitário do Porto https://orcid.org/0000-0002-3760-5121
  • Carolina Curto Department of Pediatrics, Centro Materno-Infantil do Norte, Centro Hospitalar e Universitário do Porto
  • Joana Lima Department of Pediatrics, Centro Materno-Infantil do Norte, Centro Hospitalar e Universitário do Porto https://orcid.org/0000-0002-5232-0239
  • Cláudia Correia Department of Pediatrics, Centro Materno-Infantil do Norte, Centro Hospitalar e Universitário do Porto https://orcid.org/0000-0002-4239-6096
  • Carla Teixeira Department of Pediatrics, Centro Materno-Infantil do Norte, Centro Hospitalar e Universitário do Porto; Infectious Diseases and Immunodeficiencies Unit, Department of Pediatrics, Centro Materno-Infantil do Norte, Centro Hospitalar e Universitário do Porto https://orcid.org/0000-0001-9522-9753
  • Alexandre Fernandes Department of Pediatrics, Centro Materno-Infantil do Norte, Centro Hospitalar e Universitário do Porto; Infectious Diseases and Immunodeficiencies Unit, Department of Pediatrics, Centro Materno-Infantil do Norte, Centro Hospitalar e Universitário do Porto https://orcid.org/0000-0002-0532-2178
  • Laura Marques Department of Pediatrics, Centro Materno-Infantil do Norte, Centro Hospitalar e Universitário do Porto; Infectious Diseases and Immunodeficiencies Unit, Department of Pediatrics, Centro Materno-Infantil do Norte, Centro Hospitalar e Universitário do Porto
  • Alberto Caldas-Afonso Department of Pediatrics, Centro Materno-Infantil do Norte, Centro Hospitalar e Universitário do Porto

DOI:

https://doi.org/10.25753/BirthGrowthMJ.v31.i3.27984

Keywords:

COVID-19, homecare, pediatric age

Abstract

Background: The burden of COVID-19 is reported to be less significant in pediatric patients, with lower morbidity and mortality. Our center secured daily telephone follow-up for pediatric COVID-19 outpatients during the isolation period of the pandemic. The aim of this study was to describe COVID-19 manifestations in the pediatric population.
Methods: This was a retrospective cohort study of pediatric COVID-19 patients conducted between March 2020 and September 2021. Pediatric patients with positive SARS-CoV-2 nucleic acid amplification test performed in Emergency Department, hospitalization, or pre-surgery setting in our center, and patients followed in regular appointments in our center with positive SARS-CoV-2 test performed elsewhere were included. Cases of multisystem inflammatory syndrome in children were excluded. Demographic data, medical history, and data regarding disease course and severity were collected.
Results: Two hundred and forty-two patients were included, with a median (range) age of 48 (10-144) months. Approximately one third of patients (36.0%) had at least one chronic condition, and 142 had had a prior contact with an infected relative. At diagnosis, the large majority of patients (83.9%) were symptomatic, with fever, cough, rhinorrhea, and nasal congestion as main complaints. A total of 19.8% of patients were initially hospitalized. Among the 194 patients discharged, 22 required reassessment, eight of whom needed hospitalization. Most of these (91.7%) had mild disease or were asymptomatic, while 5.8% fulfilled criteria for moderate disease and 2.5% for severe disease. Two patients required admission to the Intensive Care Unit, one of whom died.
Conclusions: In this pediatric cohort, COVID-19 presented mostly as a mild disease, with non-specific and multiple symptoms. The close follow-up conducted at our center enabled a better understanding of the disease and minimizing unnecessary emergency visits and hospitalizations, while maintaining adequate patient follow-up.

Downloads

Download data is not yet available.

References

World Health Organization - WHO timeline – available at https://www.who.int/news/item/27-04-2020-who-timeline---covid-19.

World o Meter – Coronavirus in Portugal – available at https://www.worldometers.info/coronavirus/country/portugal/.

UNICEF data hub – COVID-19 and children – available at https://data.unicef.org/covid-19-and-children/.

Dawood FS, Porucznik CA, Veguilla V, Stanford JB, Duque J, Rolfes MA, et al. Incidence rates, household infection risk, and clinical characteristics of SARS-CoV-2 infection among children and adults in Utah and New York City, New York. JAMA Pediatr. 2022;176(1):59–67. https://doi.org/10.1001/jamapediatrics.2021.4217.

World o Meter – Coronavirus Cases in World – available at https://www.worldometers.info/coronavirus/.

Leidman E, Duca LM, Omura JD, Proia K, Stephens JW, Sauber-Schatz EK. COVID-19 Trends Among Persons Aged 0-24 Years – United States, March 1-December 12, 2020. MMWR Morb Mortal Wkly Rep 2021;70:88-94.

https://doi.org/10.15585/mmwr.mm7003e1.

Li X, Xu W, Dozier M, He Y, Kirolos A, Lang Z, Song P, Theodoratou E; UNCOVER. The role of children in the transmission of SARS-CoV2: updated rapid review. J Glob Health. 2020;10(2):021101. https://doi.org/10.7189/jogh.10.021101.

Patel NA. Pediatric COVID-19: Systematic review of the literature. Am J Otolaryngol. 2020;41(5):102573. https://doi.org/10.1016/j.amjoto.2020.102573.

Chang TH, Wu JL, Chang LY. Clinical characteristics and diagnostic challenges of pediatric COVID-19: A systematic review and meta-analysis. J Formos Med Assoc. 2020;119(5):982-989. https://doi.org/10.1016/j.jfma.2020.04.007.

Kim L, Whitaker M, O’Halloran A, Kambhampati A, Chai SJ, Reingold A, et al. Hospitalization rates and characteristics of children aged <18 years hospitalized with laboratory-confirmed COVID-19 - COVID-NET, 14 States, March 1-July 25, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(32):1081-1088. https://doi.org/10.15585/mmwr.mm6932e3.

Stokes EK, Zambrano LD, Anderson KN, Marder EP, Raz KM, El Burai Felix S, et al. Coronavirus Disease 2019 Case Surveillance - United States, January 22-May 30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(24):759-765. https://doi.org/10.15585/mmwr.mm6924e2.

Bellino S, Punzo O, Rota MC, Manso M, Urdiales AM, Andrianou X, et al. Disease Severity Risk Factors for Pediatric Patients in Italy. Pediatrics. 2020;146(4):e2020009399. https://doi.org/10.1542/peds.2020-009399.

Graff K, Smith C, Silveira L, Jung S, Curran-Hays S, Jarjour j, et al. Risk Factors for Severe COVID-19 in Children. Pediatr Infect Dis J. 2021;40(4):e137-e145. https://doi.org/10.1097/INF.0000000000003043.

Downloads

Published

2022-10-19

How to Cite

1.
Salazar L, Curto C, Lima J, Correia C, Teixeira C, Fernandes A, Marques L, Caldas-Afonso A. Pediatric COVID-19 ─ What kind of disease is it?. REVNEC [Internet]. 2022Oct.19 [cited 2022Dec.7];31(3):220-5. Available from: https://revistas.rcaap.pt/nascercrescer/article/view/27984

Most read articles by the same author(s)

1 2 > >>